...
首页> 外文期刊>Brain research >Chronic neuropathic pain in mice reduces mu-opioid receptor-mediated G-protein activity in the thalamus
【24h】

Chronic neuropathic pain in mice reduces mu-opioid receptor-mediated G-protein activity in the thalamus

机译:小鼠的慢性神经性疼痛降低丘脑中μ阿片受体介导的G蛋白活性

获取原文
获取原文并翻译 | 示例
           

摘要

Neuropathic pain is a debilitating condition that is often difficult to treat using conventional pharmacological interventions and the exact mechanisms involved in the establishment and maintenance of this type of chronic pain have yet to be fully elucidated. The present studies examined the effect of chronic nerve injury on mu-opioid receptors and receptor-mediated G-protein activity within the supraspinal brain regions involved in pain processing of mice. Chronic constriction injury (CCI) reduced paw withdrawal latency, which was maximal at 10 days post-injury. [d-Ala2,(N-Me)Phe4,Gly5-OH] enkephalin (DAMGO)-stimulated [~(35)S]GTP-gammaS binding was then conducted at this time point in membranes prepared from the rostral ACC (rACC), thalamus and periaqueductal grey (PAG) of CCI and sham-operated mice. Results showed reduced DAMGO-stimulated [~(35)S] GTP7S binding in the thalamus and PAG of CCI mice, with no change in the rACC. In thalamus, this reduction was due to decreased maximal stimulation by DAMGO, with no difference in EC_(50) values. In PAG, however, DAMGO E_(max) values did not significantly differ between groups, possibly due to the small magnitude of the main effect. [~3H]Naloxone binding in membranes of the thalamus showed no significant differences in B_(max) values between CCI and sham-operated mice, indicating that the difference in G-protein activation did not result from differences in n-opioid receptor levels. These results suggest that CCI induced a region-specific adaptation of mu-opioid receptor-mediated G-protein activity, with apparent desensitization of the mu-opioid receptor in the thalamus and PAG and could have implications for treatment of neuropathic pain.
机译:神经性疼痛是一种使人衰弱的病症,使用常规药理学干预通常难以治疗,而且尚未完全阐明建立和维持这种慢性疼痛的确切机制。本研究检查了慢性神经损伤对参与小鼠疼痛处理的棘上大脑区域内阿片类鸦片受体和受体介导的G蛋白活性的影响。慢性收缩损伤(CCI)可减少爪子退缩潜伏期,这在受伤后10天达到最大。然后在此时间点在由延髓ACC(rACC)制备的膜中进行[d-Ala2,(N-Me)Phe4,Gly5-OH]脑啡肽(DAMGO)刺激的[〜(35)S]GTP-γS结合。 ,CCI和假手术小鼠的丘脑和导水管周围灰色(PAG)。结果表明,DAMGO刺激的CCI小鼠丘脑和PAG中的[〜(35)S] GTP7S结合减少,而rACC不变。在丘脑中,这种减少是由于DAMGO对最大刺激的减少,EC_(50)值无差异。但是,在PAG中,DAMGO的E_(max)值在各组之间没有显着差异,这可能是由于主要效果的幅度较小。 [〜3H]纳洛酮在丘脑膜中的结合在CCI和假手术小鼠之间显示B_(max)值无显着差异,这表明G蛋白活化的差异并非由n阿片受体水平的差异引起。这些结果表明,CCI诱导了μ阿片受体介导的G蛋白活性的区域特异性适应,丘脑和PAG中的μ阿片受体明显脱敏,可能对神经性疼痛的治疗有影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号